The 90-day double-blind trial showed a 14% drop in HbA1c and serum endotoxin fell almost to zero.
1. Life's Best Medicine Podcast episode 273 centers on Martha Carlin and the microbiome.
2. Brian Lenskis hosts Martha Carlin, who founded Biotic Quest and The Bio Collective, because her work connects stool testing, Parkinson's, and metabolic health.
3. The conversation asks what the microbiome is doing in diabetes, Parkinson's, stress, and immune function.
4. Martha says humans are about two-thirds microbial, with only one-third human cells.
5. She describes the microbiome as an internal pharmacy that produces vitamins, hormones, and neurotransmitters.
6. She says thousands of research papers now connect the microbiome to major diseases and drug metabolism.
7. Her interest began after John Carlin's Parkinson's diagnosis in 2002.
8. She says her background as an auditor and business systems analyst pushed her to study the body as a system.
9. She founded The Bio Collective and started collecting fecal samples for researchers around the globe.
10. She says a paper on Parkinson's showed tremor-dominant and posture-and-gait forms could be separated by gut bacteria.
11. Martha says she went to a Parkinson's conference, heard about mannitol stopping protein aggregation in a mouse, and bought a book on mannitol chemistry.
12. She links mannitol, xylitol, and ribitol to tubers eaten in caves and says those sugar alcohols feed mitochondrial energy pathways.
13. She says SugarShift was designed for John and later taken into a 90-day double-blind trial in diabetes.
14. She says the trial measured fasting glucose, postprandial glucose, insulin, HOMA-IR, triglycerides, HbA1c, and serum lipopolysaccharide.
15. She says HbA1c fell 14% by about 180 days and serum endotoxin dropped close to zero.
16. She says the formula also reduced sugar cravings and shifted the gut toward an anaerobic environment with more bifidobacteria.
17. Martha and Brian discuss Akkermansia, and she warns that it is a mucin degrader that can eat the mucus lining if the environment is wrong.
18. The tone is conversational and technical, with Brian pressing for practical implications while Martha moves between clinical data and personal history.
19. People interested in gut microbiome, low-carb diabetes care, or Parkinson's links will likely get the most from this episode.
20. People wanting a light, non-technical chat about health may skip it.
